The Scientist

» regulation

Most Recent

image: Europe Softens on GM Crops

Europe Softens on GM Crops

By | December 9, 2014

A new agreement in the European Union allows genetically engineered crops to be approved without member-state votes, likely allowing several GMO foods to enter the market.

0 Comments

image: New NIH IRB Guidelines Proposed

New NIH IRB Guidelines Proposed

By | December 8, 2014

A draft policy from the US National Institutes of Health suggests that clinical studies performed at multiple sites should be reviewed by a single institutional review board.

0 Comments

image: Dangerous Research Regs Released

Dangerous Research Regs Released

By | September 25, 2014

The US government releases its policy on so-called dual-use research involving dangerous pathogens that could be used for biological terrorist attacks.

0 Comments

image: Sex and Drugs

Sex and Drugs

By | July 1, 2014

Did 20th-century pharmaceutical and technological advances shape modern sexual behaviors?

2 Comments

image: That Loving Feeling

That Loving Feeling

By | July 1, 2014

There are no FDA-approved drugs to treat low sexual desire in women, but not for lack of trying.

1 Comment

image: FDA Issues Nanotechnology Guidance

FDA Issues Nanotechnology Guidance

By | June 26, 2014

Four new documents from the US Food and Drug Administration provide industry with guidelines on the use of nanotechnology in products regulated by the agency.

0 Comments

image: Week in Review: June 16–20

Week in Review: June 16–20

By | June 20, 2014

Early Neanderthal evolution; developing antivirals to combat polio; the mouth and skin microbiomes; insect-inspired, flight-stabilizing sensors

0 Comments

image: Updated Review: Tamiflu Is a Bust

Updated Review: Tamiflu Is a Bust

By | April 10, 2014

After finally getting their hands on full clinical study reports, independent reviewers say the antiviral drug is ineffective.

6 Comments

image: Stem Cell Lines Not Fit for Clinic

Stem Cell Lines Not Fit for Clinic

By | February 6, 2014

Most stem cell lines registered with the NIH don’t comply with the FDA’s guidelines for human use, according to a new report.  

0 Comments

image: Inconsistent Evidence

Inconsistent Evidence

By | January 22, 2014

More than a third of US drug approvals are based on a single large clinical trial, while others require more in-depth study, according to a new report.

0 Comments

Popular Now

  1. Unstructured Proteins Help Tardigrades Survive Desiccation
  2. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  3. Opinion: On “The Impact Factor Fallacy”
  4. Inflammation Drives Gut Bacteria Evolution
Business Birmingham